Skip to search formSkip to main contentSkip to account menu

BRL-25000

Known as: BRL 25000, BRL25000 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1986
1986
During the three years 1981-3, 134 (9.1%) of 1473 patients presenting at our clinics were found to be infected with penicillinase… 
1986
1986
The in vitro susceptibilities of various causative organisms recently isolated from patients with genital infections to BRL 25000… 
1985
1985
BRL 25000 (187.5 and 375 mg tablets), a formulation of CVA-K and AMPC in the ratio of 1:2, and AMPC (as control drug) were… 
1985
1985
Fundamental and clinical studies have been performed on BRL 25000 (clavulanic acid 1 part-amoxicillin 2 parts) granules in the… 
1985
1985
BRL 25000 granules (containing 2 parts amoxicillin and 1 part clavulanic acid) have been studied fundamentally and clinically… 
1985
1985
The authors have carried out laboratory and clinical studies on the BRL 25000 granule (containing 2 parts amoxicillin and 1 part… 
1983
1983
Synergism between amoxicillin and clavulanic acid was not expected against cephalosporinase-producing bacterial strains because…